Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.

Abstract

These results show for the first time that the level of RANKL expression by myeloma cells correlates significantly with osteolytic bone disease.